Paper Details

  1. Home
  2. Paper Details

Differentiated Thyroid Cancer-Treatment: State of the Art.

Author: GrosseJirka, HellwigDirk, MenhartKarin, SchmidbauerBenedikt

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Overview

Differentiated thyroid cancer (DTC) is a rare type of cancer that usually has a good outcome. Treatment typically involves surgery, radioactive iodine, and thyroid hormone replacement. While most cases are cured with these methods, new treatments are being developed for rare cases that don't respond to radioactive iodine. These newer medications can slow down tumor growth but may have serious side effects and are only used for patients with severe symptoms.
Paper Details　
Original Abstract of the Article :
Differentiated thyroid cancer (DTC) is a rare malignant disease, although its incidence has increased over the last few decades. It derives from follicular thyroid cells. Generally speaking, the prognosis is excellent. If treatment according to the current guidelines is given, cases of recurrence or...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5486113/

データ提供：米国国立医学図書館（NLM）

Differentiated Thyroid Cancer: A Rare but Treatable Disease

This article delves into the treatment of [differentiated thyroid cancer (DTC)], a rare malignancy with a generally favorable prognosis. The authors emphasize the importance of [specialized expertise] in managing DTC. While [surgery and radioiodine therapy] remain the standard treatments, they also discuss emerging options for [radioiodine-refractory tumors], highlighting the use of [multikinase or tyrosine kinase inhibitors]. The study provides a comprehensive overview of current best practices for treating DTC.

Targeting Thyroid Cancer: A Multi-Pronged Approach

The study underscores the importance of a [multidisciplinary approach] to treating DTC, involving [surgeons, nuclear medicine specialists, and oncologists]. This is like a well-coordinated caravan traversing a desert landscape, each member playing a crucial role in ensuring the success of the journey. This approach is essential for effective treatment and optimal patient outcomes.

Hope for Radioiodine-Refractory Tumors

The study sheds light on new therapeutic options for [radioiodine-refractory tumors], a challenging aspect of DTC. The emergence of [multikinase or tyrosine kinase inhibitors] offers a glimmer of hope for patients with these resistant tumors. This is like discovering a hidden spring of water in the desert, providing a vital resource for those struggling with this challenging condition.

Dr. Camel's Conclusion

This research is a valuable guide for clinicians and patients seeking the most effective treatments for differentiated thyroid cancer. The study emphasizes the importance of specialized expertise, multidisciplinary care, and ongoing research to improve outcomes for individuals with DTC.
Date :
  1. Date Completed 2018-03-19
  2. Date Revised 2022-03-31
Further Info :

Pubmed ID

28629126

DOI: Digital Object Identifier

PMC5486113

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.